95 related articles for article (PubMed ID: 10734181)
1. Synthesis and characterization of a fluorescent substrate for the N-arachidonoylethanolamine (anandamide) transmembrane carrier.
Muthian S; Nithipatikom K; Campbell WB; Hillard CJ
J Pharmacol Exp Ther; 2000 Apr; 293(1):289-95. PubMed ID: 10734181
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion.
Hillard CJ; Edgemond WS; Jarrahian A; Campbell WB
J Neurochem; 1997 Aug; 69(2):631-8. PubMed ID: 9231721
[TBL] [Abstract][Full Text] [Related]
3. Studies of anandamide accumulation inhibitors in cerebellar granule neurons: comparison to inhibition of fatty acid amide hydrolase.
Hillard CJ; Shi L; Tuniki VR; Falck JR; Campbell WB
J Mol Neurosci; 2007 Sep; 33(1):18-24. PubMed ID: 17901541
[TBL] [Abstract][Full Text] [Related]
4. Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase.
van der Stelt M; van Kuik JA; Bari M; van Zadelhoff G; Leeflang BR; Veldink GA; Finazzi-Agrò A; Vliegenthart JF; Maccarrone M
J Med Chem; 2002 Aug; 45(17):3709-20. PubMed ID: 12166944
[TBL] [Abstract][Full Text] [Related]
5. RNA interference-mediated knockdown of dynamin 2 reduces endocannabinoid uptake into neuronal dCAD cells.
McFarland MJ; Bardell TK; Yates ML; Placzek EA; Barker EL
Mol Pharmacol; 2008 Jul; 74(1):101-8. PubMed ID: 18436710
[TBL] [Abstract][Full Text] [Related]
6. Further evidence for the existence of a specific process for the membrane transport of anandamide.
Ligresti A; Morera E; Van Der Stelt M; Monory K; Lutz B; Ortar G; Di Marzo V
Biochem J; 2004 May; 380(Pt 1):265-72. PubMed ID: 14969584
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of anandamide: evidence for cellular diversity.
Hillard CJ; Jarrahian A
Neuropharmacology; 2005 Jun; 48(8):1072-8. PubMed ID: 15910883
[TBL] [Abstract][Full Text] [Related]
8. N-Morpholino- and N-diethyl-analogues of palmitoylethanolamide increase the sensitivity of transfected human vanilloid receptors to activation by anandamide without affecting fatty acid amidohydrolase activity.
Vandevoorde S; Lambert DM; Smart D; Jonsson KO; Fowler CJ
Bioorg Med Chem; 2003 Mar; 11(6):817-25. PubMed ID: 12614867
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis--a difficult issue to handle.
Fowler CJ; Tiger G; Ligresti A; López-Rodríguez ML; Di Marzo V
Eur J Pharmacol; 2004 May; 492(1):1-11. PubMed ID: 15145699
[TBL] [Abstract][Full Text] [Related]
10. Characterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma and rat RBL-2H3 basophilic leukaemia cells: comparison with anandamide.
Jacobsson SO; Fowler CJ
Br J Pharmacol; 2001 Apr; 132(8):1743-54. PubMed ID: 11309246
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships among N-arachidonylethanolamine (Anandamide) head group analogues for the anandamide transporter.
Jarrahian A; Manna S; Edgemond WS; Campbell WB; Hillard CJ
J Neurochem; 2000 Jun; 74(6):2597-606. PubMed ID: 10820223
[TBL] [Abstract][Full Text] [Related]
12. The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors.
Bisogno T; MacCarrone M; De Petrocellis L; Jarrahian A; Finazzi-Agrò A; Hillard C; Di Marzo V
Eur J Biochem; 2001 Apr; 268(7):1982-9. PubMed ID: 11277920
[TBL] [Abstract][Full Text] [Related]
13. Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes.
Maccarrone M; De Petrocellis L; Bari M; Fezza F; Salvati S; Di Marzo V; Finazzi-Agrò A
Arch Biochem Biophys; 2001 Sep; 393(2):321-8. PubMed ID: 11556820
[TBL] [Abstract][Full Text] [Related]
14. Acyl-based anandamide uptake inhibitors cause rapid toxicity to C6 glioma cells at pharmacologically relevant concentrations.
De Lago E; Gustafsson SB; Fernández-Ruiz J; Nilsson J; Jacobsson SO; Fowler CJ
J Neurochem; 2006 Oct; 99(2):677-88. PubMed ID: 16899063
[TBL] [Abstract][Full Text] [Related]
15. Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide.
Bisogno T; Hanus L; De Petrocellis L; Tchilibon S; Ponde DE; Brandi I; Moriello AS; Davis JB; Mechoulam R; Di Marzo V
Br J Pharmacol; 2001 Oct; 134(4):845-52. PubMed ID: 11606325
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of rat C6 glioma cell proliferation by endogenous and synthetic cannabinoids. Relative involvement of cannabinoid and vanilloid receptors.
Jacobsson SO; Wallin T; Fowler CJ
J Pharmacol Exp Ther; 2001 Dec; 299(3):951-9. PubMed ID: 11714882
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol-dependent modulation of type 1 cannabinoid receptors in nerve cells.
Bari M; Paradisi A; Pasquariello N; Maccarrone M
J Neurosci Res; 2005 Jul; 81(2):275-83. PubMed ID: 15920744
[TBL] [Abstract][Full Text] [Related]
18. Cellular accumulation of anandamide: consensus and controversy.
Hillard CJ; Jarrahian A
Br J Pharmacol; 2003 Nov; 140(5):802-8. PubMed ID: 12970089
[TBL] [Abstract][Full Text] [Related]
19. Anandamide uptake explained?
Fowler CJ
Trends Pharmacol Sci; 2012 Apr; 33(4):181-5. PubMed ID: 22297258
[TBL] [Abstract][Full Text] [Related]
20. A role for the anandamide membrane transporter in TRPV1-mediated neurosecretion from trigeminal sensory neurons.
Price TJ; Patwardhan AM; Flores CM; Hargreaves KM
Neuropharmacology; 2005 Jul; 49(1):25-39. PubMed ID: 15992578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
